(Q73175622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Shouki Bazarbashi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

A A Ezzat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E M Ibrahim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D S Ajarim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M M Rahal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M A Raja

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A M Tulbah

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Kandil

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

O A Al-Malik

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

237-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072788%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006434406989

1 November 2019

exact match

0 references

cites work

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Primary chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Primary medical (neo-adjuvant) chemotherapy for operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Primary systemic therapy for operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

A phase II trial of circadian-timed paclitaxel and cisplatin therapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Breast cancer in the eastern province of Saudi Arabia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Results of treating stage iii carcinoma of the breast by primary radiation therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006434406989

7 January 2021